Simply realize the digital transformationIn line with this motto, Siemens presented at ACHEMA Pulse 2021 together with experts and customers new opportunities for companies in the process industry with a special focus on the chemical and pharmaceutical industry. Get inspired and watch our show "Siemens&Guests" here now on demand.
Combine the real and digital worlds
The process industries are facing urgent and rapidly changing challenges. The COVID-19 pandemic has transformed global supply chains and the demand for goods virtually overnight. At the same time, industry-specific regulations and standards are creating new framework conditions. Digitalization and automation are the levers for mastering these challenges. In addition to intelligently linking and analyzing data, companies obtain a better overview of workflows and can adapt their processes to changing requirements more quickly.
The Digital Enterprise makes this possible by combining the real and digital worlds and with solutions for simulation, virtual processes, remote accesses, and connectivity, as well as service offerings for the digital transformation.
Whether virtual or real, every ACHEMA is close to my heart. I’m looking forward to inspiring customer discussions and a dialog with the community.Eckard Eberle, CEO Process Automation
How process industry can become resilient and sustainable
Learning about our customers’ challenges and perspectives in a lively, open discussion:
- What challenges did the companies face in the past year and how did they master them?
- What future challenges do they foresee for their companies and their industries?
- How does the topic of sustainability come into play in their industry and what does it involve?
- Why are partnerships and cooperation in ecosystems so important (in all this)?
Dr. Sierk Pötting (CFO BioNTech), Dr. Christian Hartel (CEO Wacker Chemie), Dr. René Fáber (Head of Bioprocess Solutions Division, Member of the Executive Board, Sartorius Germany), Cedrik Neike (CEO Siemens Digital Industries)
Ramping up production in the quantities needed and accelerating clinical trials in the timeframes required to combat pandemics is one of the biggest challenges the pharma industry has ever faced.
As trusted partners, Siemens, GSK and Atos have successfully just doing that via a new digital process twin.
In our talk with Benedikt Efker (Head of Digitalization Production & Assets at LANXESS) and Ulrike Lehnhof (Corporate Account Manager at Siemens) we are focusing on the digital transformation in the field.
In the chemical industry, the biggest challenge is to ensure that the system runs reliably and safely. The "Siemens Digital Worker" is a concept that enables operating personnel to digitize and automate work in the field using the latest technologies such as AR / VR. The concept supports the user in digitizing work processes in process systems and in paperless processing with remote access thanks to electronic documentation, access information and guidance through intelligent devices.
How will the Chemical Industry transform in the next years? What will production and/or operation look like in the future?
Join Steffen Wagner (CTO Process Automation at Siemens AG) and Miguel Angel Fernandez (VP Sales, Head of Verticals Chemicals, Glass, Oil&Gas at Siemens AG) in their exiting discussion about the future of process industries with Dr. Bernhard Kirchmair (CDO at Vinci Energies) and Dirk Ramhorst (CIO and CDO at Wacker Chemie AG), answering these questions and more.
What manufacturer require for staying competitive on the long run, are concepts to realize flexibility in production but also in plant design and construction.
This is why modular production is one of the hot topics, that we will discuss in detail with our customer Dr. Hans-Joachim Neumann (Executive Vice President, Electronics | Integrated Supply Chain, Merck KGaA, Darmstadt, Germany)
The Medicines Manufacturing Innovation Centre (MMIC) is a collaboration between CPI, the University of Strathclyde, founding industry partners GSK and AstraZeneca, and Government funding partners Scottish Enterprise and UK Research and Innovation. This collaborative partnership business model will help the MMIC achieve its aim to benefit patients, the environment and the UK economy through accelerating the introduction on new technology into medicines manufacturing, via flagship Grand Challenge projects.
By bringing together a digital twin and continuous manufacturing technologies into a digital test-bed, Grand Challenge 1 will fulfil its aim to produce oral solid dose medicines more robustly and efficiently. The contribution by Siemens will also support Grand Challenge 2's focus on faster more flexible delivery of medicines to patients via just-in-time packing and Qualified Person release and enabling adaptive clinical trial supply.